| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,151,697 |
|
|
Indirect Shares
|
265,510 |
|
|
| Direct
Value |
$8,534,238 |
|
|
|
Indirect Value
|
$109,674 |
|
|
| Total
Shares |
1,417,207 |
|
|
| Total
Value |
$8,643,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CELG |
Celgene Corp |
Director |
– • – |
2014-02-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,020 |
226,764 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-07-23 |
4 |
OE |
$12.81 |
$280,280 |
D/D |
20,000 |
228,027 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2014-07-24 |
4 |
OE |
$27.69 |
$138,450 |
D/D |
5,000 |
229,358 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2011-08-02 |
4 |
B |
$6.82 |
$682,230 |
D/D |
100,000 |
231,004 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2018-05-11 |
4 |
S |
$4.57 |
$138,380 |
I/I |
(30,000) |
235,720 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2018-01-29 |
4 |
B |
$10.00 |
$900,000 |
D/D |
90,000 |
236,770 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2009-12-30 |
4/A |
GD |
$0.00 |
$0 |
I/I |
550 |
238,127 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2009-12-28 |
4/A |
GD |
$0.00 |
$0 |
I/I |
550 |
238,677 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2009-03-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
875 |
239,227 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-12-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
960 |
240,102 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2015-08-17 |
4 |
B |
$6.93 |
$104,018 |
D/D |
15,000 |
240,472 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-12-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(100,000) |
241,062 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-05-09 |
4 |
S |
$34.14 |
$3,088,825 |
I/I |
(90,395) |
245,552 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2015-08-20 |
4 |
B |
$6.64 |
$39,867 |
D/D |
6,000 |
246,472 |
2.39 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2015-08-24 |
4 |
B |
$6.20 |
$15,698 |
D/D |
2,532 |
249,004 |
2.39 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2015-08-25 |
4 |
B |
$6.40 |
$9,395 |
D/D |
1,468 |
250,472 |
2.39 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2011-10-25 |
4 |
B |
$5.50 |
$137,500 |
D/D |
25,000 |
256,004 |
2.39 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2015-08-26 |
4 |
B |
$6.05 |
$60,500 |
D/D |
10,000 |
260,472 |
2.39 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-12-01 |
4 |
AS |
$12.96 |
$129,618 |
D/D |
(10,000) |
261,032 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2015-12-29 |
4 |
B |
$7.09 |
$886,613 |
D/D |
125,000 |
262,637 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2010-03-10 |
4 |
A |
$0.00 |
$0 |
I/I |
37,962 |
263,153 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-01-13 |
4 |
OE |
$5.05 |
$8,893 |
D/D |
1,761 |
264,398 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2018-05-10 |
4 |
S |
$4.60 |
$12,949 |
I/I |
(2,815) |
265,720 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-02-08 |
4 |
OE |
$5.05 |
$8,888 |
D/D |
1,760 |
266,158 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-10-08 |
4 |
AS |
$12.06 |
$120,600 |
D/D |
(10,000) |
267,855 |
0 |
- |
|
373 Records found
|
|
Page 10 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
